PPIs targeted with new prescribing restrictions
Higher-strength drugs will need streamlined authority approval
Subsidised scripts for higher-strength PPIs will require streamlined authority approval from this month.
The restrictions are part of the PBAC’s ongoing attempt to discourage the use of higher doses of the common drugs.
